
MK-677, also known in the literature as ibutamoren, is a synthetic small-molecule compound studied in laboratory settings for its activity as a growth hormone secretagogue receptor (GHSR, ghrelin receptor) agonist. In controlled experimental models, MK-677 is utilized to examine modulation of the growth hormone (GH) and insulin-like growth factor-1 (IGF-1) axis through receptor-mediated signaling pathways.
Preclinical and translational research systems commonly evaluate its effects on pulsatile GH signaling dynamics, endocrine feedback regulation, and downstream transcriptional responses under defined laboratory conditions. Investigators frequently employ in vitro assays and animal models to study neuroendocrine signaling, receptor binding kinetics, and pathway-level interactions associated with somatotropic axis modulation. These structured research environments allow detailed investigation of receptor-dependent endocrine mechanisms without implying human application.
All Hanobi® research compounds are manufactured under rigorous quality control standards and sourced from independently vetted, accredited suppliers. Each batch undergoes analytical verification to confirm identity and purity, ensuring consistency, traceability, and compliance with federal and state regulations governing research-use materials.
Capsules are supplied solely as inert containers for the dry transport, storage, and handling of laboratory research materials. They are not dosage forms and are not intended for ingestion or administration. They must not be used as drug delivery systems, consumed, or administered in any manner.
Not for use in humans or animals. Not for diagnostic or therapeutic purposes.